NCT05512481
- Conditions
- Acral Melanoma, Apatinib, Camrelizumab, +15 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.
NCT05512481
NCT05231655
NCT06272864
NCT05877430
NCT06281678
NCT06727630
NCT04787042
NCT06240143
NCT06680323